How to obtain access to medications without the Decision Forum’s approval

CD73 expression as a resistance mechanism in advanced EGFR-mutated non-small cell lung cancer.

Frontiers in oncology·2026

Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study).

Lung cancer (Amsterdam, Netherlands)·2026

Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study.

FEBS open bio·2026

Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types.

NPJ precision oncology·2026

Profiling of Extracellular Vesicles of Non-Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance.

Journal of extracellular vesicles·2026

Too much or too little? The trajectory of systemic anti-cancer treatment throughout the last year of life of lung cancer patients in Norway.

BJC reports·2025

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Ductus arteriosus aneurysm in a neonate with inspiratory stridor.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Understanding non-medical prescribers' antimicrobial prescribing and stewardship competency: A scoping review.

Research in social & administrative pharmacy : RSAP·2026

False Friends in Fluorescence - Simple HPLC Evaluation of False Positive Fragment Hits in a DiFMUP Assay for Protein Tyrosine Phosphatase 1B.

Drug design, development and therapy·2026

Insurance Noncoverage of Interventional Pain Procedures: Paving the Road Toward the Second Prescription Opioid Crisis.

Journal of pain research·2026

Rebalancing innovation, affordability, and access for orphan drugs in the European Union.

The Lancet regional health. Europe·2026

Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.

Therapeutic innovation & regulatory science·2026

The Hidden Burden of Parkinson's Disease in Cambodia: A Call to Action.

Public health challenges·2026

Related Experiment Videos

How to obtain access to medications without the Decision Forum’s approval

Related Concept Videos

CD73 expression as a resistance mechanism in advanced EGFR-mutated non-small cell lung cancer.

Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study).

Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study.

Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types.

Profiling of Extracellular Vesicles of Non-Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance.

Too much or too little? The trajectory of systemic anti-cancer treatment throughout the last year of life of lung cancer patients in Norway.

A woman in her 70s with chest pain and elevated troponin T levels.

Ductus arteriosus aneurysm in a neonate with inspiratory stridor.

Understanding non-medical prescribers' antimicrobial prescribing and stewardship competency: A scoping review.

False Friends in Fluorescence - Simple HPLC Evaluation of False Positive Fragment Hits in a DiFMUP Assay for Protein Tyrosine Phosphatase 1B.

Insurance Noncoverage of Interventional Pain Procedures: Paving the Road Toward the Second Prescription Opioid Crisis.

Rebalancing innovation, affordability, and access for orphan drugs in the European Union.

Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.

The Hidden Burden of Parkinson's Disease in Cambodia: A Call to Action.

Related Experiment Videos

How to obtain access to medications without the Decision Forum’s approval

Related Concept Videos

Related Articles